nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—Weight decreased—Bleomycin—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Estazolam—Confusional state—Teniposide—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Estazolam—Oedema—Teniposide—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Estazolam—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Estazolam—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Estazolam—Agitation—Fludarabine—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Estazolam—Stupor—Methotrexate—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Estazolam—Malaise—Fludarabine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Estazolam—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Estazolam—Leukopenia—Fludarabine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Estazolam—Haematuria—Bleomycin—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Estazolam—Pruritus—Mechlorethamine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Estazolam—Cough—Fludarabine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Estazolam—Convulsion—Fludarabine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Estazolam—Myalgia—Fludarabine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Estazolam—Arthralgia—Fludarabine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Estazolam—Discomfort—Fludarabine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Estazolam—Dyspnoea—Teniposide—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Estazolam—Confusional state—Fludarabine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Estazolam—Depression—Carmustine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Estazolam—Oedema—Fludarabine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Estazolam—Decreased appetite—Teniposide—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Estazolam—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Estazolam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Estazolam—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Estazolam—Rash—Mechlorethamine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Estazolam—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Estazolam—Weight decreased—Vincristine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Estazolam—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Estazolam—Flushing—Bleomycin—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Estazolam—Depression—Vincristine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Estazolam—Weight increased—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Estazolam—Weight decreased—Mitoxantrone—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Estazolam—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Estazolam—Feeling abnormal—Teniposide—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Estazolam—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Estazolam—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Estazolam—Chills—Bleomycin—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Estazolam—Sweating—Vincristine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Estazolam—Nausea—Mechlorethamine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Estazolam—Urticaria—Teniposide—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Estazolam—Oliguria—Methotrexate—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Estazolam—Body temperature increased—Teniposide—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Estazolam—Abdominal pain—Teniposide—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Estazolam—Paraesthesia—Fludarabine—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Estazolam—Hallucination—Carmustine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Estazolam—Sweating—Mitoxantrone—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Estazolam—Dyspnoea—Fludarabine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Estazolam—Haematuria—Mitoxantrone—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Estazolam—Dyspepsia—Fludarabine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Estazolam—Ulcer—Methotrexate—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Estazolam—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Estazolam—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Estazolam—Decreased appetite—Fludarabine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Estazolam—Visual impairment—Carmustine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Estazolam—Hallucination—Vincristine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Estazolam—Constipation—Fludarabine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Estazolam—Pain—Fludarabine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Estazolam—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Estazolam—Hypersensitivity—Teniposide—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Estazolam—Flushing—Carmustine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Estazolam—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Estazolam—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Estazolam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Estazolam—Asthenia—Teniposide—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Estazolam—Melaena—Methotrexate—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Estazolam—Malaise—Bleomycin—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Estazolam—Pruritus—Teniposide—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Estazolam—Arrhythmia—Carmustine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Estazolam—Leukopenia—Bleomycin—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Estazolam—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Estazolam—Body temperature increased—Fludarabine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Estazolam—Malnutrition—Carmustine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Estazolam—Cough—Bleomycin—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Estazolam—Chest pain—Bleomycin—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Estazolam—Myalgia—Bleomycin—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Estazolam—Back pain—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Estazolam—Discomfort—Bleomycin—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Estazolam—Chills—Mitoxantrone—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Estazolam—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Estazolam—Confusional state—Bleomycin—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Estazolam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Estazolam—Tremor—Carmustine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Estazolam—Oedema—Bleomycin—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Estazolam—Back pain—Vincristine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Estazolam—Vomiting—Teniposide—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Estazolam—Agitation—Carmustine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Estazolam—Asthenia—Fludarabine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Estazolam—Rash—Teniposide—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Estazolam—Dermatitis—Teniposide—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Estazolam—Headache—Teniposide—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Estazolam—Pruritus—Fludarabine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Estazolam—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Estazolam—Back pain—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Estazolam—Leukopenia—Carmustine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Estazolam—Agitation—Vincristine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Estazolam—Photosensitivity—Methotrexate—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Estazolam—Convulsion—Carmustine—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Estazolam—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Estazolam—Nausea—Teniposide—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Estazolam—Leukopenia—Vincristine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Estazolam—Chest pain—Carmustine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Estazolam—Myalgia—Carmustine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Estazolam—Anxiety—Carmustine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Estazolam—Paraesthesia—Bleomycin—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Estazolam—Malaise—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Estazolam—Dyspnoea—Bleomycin—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Estazolam—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Estazolam—Convulsion—Vincristine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Estazolam—Confusional state—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Estazolam—Oedema—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Estazolam—Decreased appetite—Bleomycin—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Estazolam—Myalgia—Vincristine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Estazolam—Cough—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Estazolam—Vomiting—Fludarabine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Estazolam—Convulsion—Mitoxantrone—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Estazolam—Rash—Fludarabine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Estazolam—Dermatitis—Fludarabine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Estazolam—Pain—Bleomycin—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Estazolam—Headache—Fludarabine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Estazolam—Myalgia—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Estazolam—Chest pain—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Estazolam—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Estazolam—Anxiety—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Estazolam—Discomfort—Mitoxantrone—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Estazolam—Oedema—Vincristine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Estazolam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Estazolam—Confusional state—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Estazolam—Oedema—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Estazolam—Nausea—Fludarabine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Estazolam—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Estazolam—Shock—Mitoxantrone—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Estazolam—Urticaria—Bleomycin—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Estazolam—Body temperature increased—Bleomycin—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Estazolam—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Estazolam—Paraesthesia—Carmustine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Estazolam—Mood swings—Methotrexate—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Estazolam—Dyspnoea—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Estazolam—Somnolence—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Estazolam—Ataxia—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Estazolam—Decreased appetite—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Estazolam—Paraesthesia—Vincristine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Estazolam—Pain—Carmustine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Estazolam—Constipation—Carmustine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Estazolam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Estazolam—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Estazolam—Decreased appetite—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Estazolam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Estazolam—Somnolence—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Estazolam—Feeling abnormal—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Estazolam—Asthenia—Bleomycin—lymphatic system cancer	0.002	0.002	CcSEcCtD
Estazolam—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Estazolam—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Estazolam—Constipation—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Estazolam—Pain—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Estazolam—Asthma—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Estazolam—Pruritus—Bleomycin—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Estazolam—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Estazolam—Pain—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Estazolam—Constipation—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Estazolam—Body temperature increased—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Estazolam—Abdominal pain—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Estazolam—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Estazolam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Estazolam—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Estazolam—Abdominal pain—Vincristine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Estazolam—Body temperature increased—Vincristine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Estazolam—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Estazolam—Urticaria—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Estazolam—Hypersensitivity—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Estazolam—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Estazolam—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Estazolam—Vomiting—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Estazolam—Depression—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Estazolam—Rash—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Estazolam—Dermatitis—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Estazolam—Asthenia—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Estazolam—Hypersensitivity—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Estazolam—Sweating—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Estazolam—Haematuria—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Estazolam—Epistaxis—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Estazolam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Estazolam—Asthenia—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Estazolam—Nausea—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Estazolam—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Estazolam—Asthenia—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Estazolam—Dizziness—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Estazolam—Pharyngitis—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Estazolam—Vomiting—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Estazolam—Dizziness—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Estazolam—Rash—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Estazolam—Dermatitis—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Estazolam—Visual impairment—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Estazolam—Headache—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Estazolam—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Estazolam—Tinnitus—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Estazolam—Vomiting—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Estazolam—Rash—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Estazolam—Dermatitis—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Estazolam—Headache—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Estazolam—Nausea—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Estazolam—Vomiting—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Estazolam—Rash—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Estazolam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Estazolam—Chills—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Estazolam—Headache—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Estazolam—Malnutrition—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Estazolam—Nausea—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Estazolam—Nausea—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Estazolam—Back pain—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Estazolam—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Estazolam—Malaise—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Estazolam—Leukopenia—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Estazolam—Cough—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Estazolam—Convulsion—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Estazolam—Arthralgia—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Estazolam—Chest pain—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Estazolam—Myalgia—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Estazolam—Discomfort—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Estazolam—Confusional state—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Estazolam—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Estazolam—Paraesthesia—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Estazolam—Dyspnoea—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Estazolam—Somnolence—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Estazolam—Dyspepsia—Methotrexate—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Estazolam—Decreased appetite—Methotrexate—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Estazolam—Pain—Methotrexate—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Estazolam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Estazolam—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000922	0.000922	CcSEcCtD
Estazolam—Urticaria—Methotrexate—lymphatic system cancer	0.000896	0.000896	CcSEcCtD
Estazolam—Abdominal pain—Methotrexate—lymphatic system cancer	0.000892	0.000892	CcSEcCtD
Estazolam—Body temperature increased—Methotrexate—lymphatic system cancer	0.000892	0.000892	CcSEcCtD
Estazolam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000831	0.000831	CcSEcCtD
Estazolam—Asthenia—Methotrexate—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Estazolam—Pruritus—Methotrexate—lymphatic system cancer	0.000798	0.000798	CcSEcCtD
Estazolam—Dizziness—Methotrexate—lymphatic system cancer	0.000746	0.000746	CcSEcCtD
Estazolam—Vomiting—Methotrexate—lymphatic system cancer	0.000717	0.000717	CcSEcCtD
Estazolam—Rash—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Estazolam—Dermatitis—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Estazolam—Headache—Methotrexate—lymphatic system cancer	0.000707	0.000707	CcSEcCtD
Estazolam—Nausea—Methotrexate—lymphatic system cancer	0.00067	0.00067	CcSEcCtD
